AAAAAA

   
Results: 1-11 |
Results: 11

Authors: SJOGREN S INGANAS M LINDGREN A HOLMBERG L BERGH J
Citation: S. Sjogren et al., PROGNOSTIC AND PREDICTIVE VALUE OF C-ERBB-2 OVEREXPRESSION IN PRIMARYBREAST-CANCER, ALONE AND IN COMBINATION WITH OTHER PROGNOSTIC MARKERS, Journal of clinical oncology, 16(2), 1998, pp. 462-469

Authors: NORBERG T LENNERSTRAND J INGANAS M BERGH J
Citation: T. Norberg et al., COMPARISON BETWEEN P53 PROTEIN MEASUREMENTS USING THE LUMINOMETRIC IMMUNOASSAY AND IMMUNOHISTOCHEMISTRY WITH DETECTION OF P53 GENE-MUTATIONS USING CDNA SEQUENCING IN HUMAN BREAST-TUMORS, International journal of cancer, 79(4), 1998, pp. 376-383

Authors: WILLIAMS C NORBERG T AHMADIAN A PONTEN F BERGH J INGANAS M LUNDEBERG J UHLEN M
Citation: C. Williams et al., ASSESSMENT OF SEQUENCE-BASED P53 GENE ANALYSIS IN HUMAN BREAST-CANCER- MESSENGER-RNA IN COMPARISON WITH GENOMIC DNA TARGETS, Clinical chemistry, 44(3), 1998, pp. 455-462

Authors: FALETTE N PAPERIN MP TREILLEUX I GRATADOUR AC PELOUX N MIGNOTTE H TOOKE N LOFMAN E INGANAS M BREMOND A OZTURK M PUISIEUX A
Citation: N. Falette et al., PROGNOSTIC VALUE OF P53 GENE-MUTATIONS IN A LARGE SERIES OF NODE-NEGATIVE BREAST-CANCER PATIENTS, Cancer research, 58(7), 1998, pp. 1451-1455

Authors: PLATZ A HANSSON J MANSSONBRAHME E LAGERLOF B LINDER S LUNDQVIST E SEVIGNY P INGANAS M RINGBORG U
Citation: A. Platz et al., SCREENING OF GERMLINE MUTATIONS IN THE CDKN2A AND CDKN2B GENES IN SWEDISH FAMILIES WITH HEREDITARY CUTANEOUS MELANOMA, Journal of the National Cancer Institute, 89(10), 1997, pp. 697-702

Authors: SJOGREN S INGANAS M NORBERG T LINDGREN A NORDGREN H HOLMBERG L BERGH J
Citation: S. Sjogren et al., THE P53 GENE IN BREAST-CANCER - PROGNOSTIC VALUE OF COMPLEMENTARY-DNASEQUENCING VERSUS IMMUNOHISTOCHEMISTRY, Journal of the National Cancer Institute, 88(3-4), 1996, pp. 173-182

Authors: PLATZ A RINGBORG U LAGERLOF B LUNDQVIST E SEVIGNY P INGANAS M
Citation: A. Platz et al., MUTATIONAL ANALYSIS OF THE CDKN2 GENE IN METASTASES FROM PATIENTS WITH CUTANEOUS MALIGNANT-MELANOMA, British Journal of Cancer, 73(3), 1996, pp. 344-348

Authors: JANSSON T INGANAS M SJOGREN S NORBERG T LINDGREN A HOLMBERG L BERGH J
Citation: T. Jansson et al., P53 STATUS PREDICTS SURVIVAL IN BREAST-CANCER PATIENTS TREATED WITH OR WITHOUT POSTOPERATIVE RADIOTHERAPY - A NOVEL HYPOTHESIS BASED ON CLINICAL FINDINGS, Journal of clinical oncology, 13(11), 1995, pp. 2745-2751

Authors: SEVIGNY P BJORKESTEN L PERNEMALM P INGANAS M ANDELL Y ERIKSSON S NORBERG T
Citation: P. Sevigny et al., EVALUATION OF A LARGE NUMBER OF BREAST-TUMOR SAMPLES PROCESSED BY AUTOMATIC DNA-SEQUENCING OF THE P53 GENE, Clinical chemistry, 41(6), 1995, pp. 221-221

Authors: SEVIGNY P LUNDQVIST E INGANAS M
Citation: P. Sevigny et al., ANALYSIS OF MELANOMA SAMPLES BY PCR SSCP AND AUTOMATIC DNA-SEQUENCINGOF THE P16 GENE/, Clinical chemistry, 41(6), 1995, pp. 227-227

Authors: ANDELI Y ERIKSSON S INGANAS M NORBERG T SEVIGNY P
Citation: Y. Andeli et al., A NEW APPROACH IN AUTOMATED DNA-SEQUENCING TO ANALYZE THE P53 GENE INA LARGE NUMBER OF BREAST-CANCER PATIENTS, Clinical chemistry, 40(12), 1994, pp. 2337-2337
Risultati: 1-11 |